Stay updated on Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe study history page now includes new sections for Contacts/Locations and Study Status, expanding access to site contacts and the current trial status. An added numeric item likely represents a version or count marker associated with the update.SummaryDifference0.4%

- Check9 days agoChange DetectedAdds quick access to eligibility (Check who can join) and contact information (Find Contact Information) on the study record page. Updates the revision badge to v3.6.0 and removes the previous v3.5.5 entry.SummaryDifference0.4%

- Check16 days agoChange DetectedA new revision entry v3.5.5 was added to the record history, indicating a small update to the page's metadata; the previous revision v3.5.4 is removed from the visible history.SummaryDifference0.1%

- Check30 days agoChange DetectedThe record history now includes new sections for Contacts/Locations and Study Status, reflecting updates to who to contact and the trial's current status; an entry dated 2026-05-05 was removed from the history.SummaryDifference0.4%

- Check37 days agoChange DetectedFooter revision updated from v3.5.3 to v3.5.4, indicating a general site release; no study records or page content are altered by this update.SummaryDifference0.1%

- Check45 days agoChange DetectedA new 'Study Status' entry is added to the Record History, and a new version entry (version 29) appears, reflecting updated status-tracking on the study's history page.SummaryDifference0.3%

Stay in the know with updates to Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.